EFHD1 may turn fatty liver disease into injury, with inhibition reducing scarring by up to 60%

Obesity-related metabolic liver illness affects hundreds of millions of radical worldwide, but lone immoderate of those livers make scarring, go inflamed and yet fail. University of Utah researchers person identified a protein, EFHD1, that appears to thrust that modulation by triggering an out-of-place antiviral immune response.